FIELD: medicine.
SUBSTANCE: invention relates to medicine and pharmacology, specifically to use of O-(((4-hydroxy-3,5-di(1,7,7-trimethylbicyclo[2.2.1]hept-exo-2-yl)benzyl)oxy)ethyl)-O-(2-hydroxyethyl) - (1→4) -α-D-glucan with content of 2,6-diisobornyl-4-methylenephenol fragments from 0.5 to 6.0 wt. % as a neuroprotective agent.
EFFECT: invention provides expansion of the nomenclature of agents possessing neuroprotective activity.
1 cl, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS FOR CEREBRAL BLOOD FLOW INCREASE | 2016 |
|
RU2655810C2 |
| DRUG WITH COMPLEX PHARMACOLOGICAL EFFECT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CORRECTION OF CEREBRAL CIRCULATION DISORDERS, TREATMENT OF CONSEQUENCES OF CEREBROVASCULAR DISEASES (OPTIONS) | 2019 |
|
RU2757874C1 |
| AGENT RELIEVING POSTINFARCTION MYOCARDIAL REMODELING | 2020 |
|
RU2740895C1 |
| AGENT IMPROVING RHEOLOGICAL PROPERTIES OF BLOOD | 2013 |
|
RU2546297C1 |
| NEUROPROTECTOR | 2009 |
|
RU2406488C1 |
| PHARMACEUTICAL INJECTION FORM OF HYDROPHILIC CONJUGATE OF HYDROXYETHYLAMYLUM AND 2,6-DIISOBORNYL-4-METHYLPHENOL, METHOD FOR ITS PRODUCTION AND APPLICATIONS FOR CARDIOVASCULAR DISEASES TREATMENT | 2016 |
|
RU2625039C1 |
| HYDROPHILIC CONCENTRATE OF DERIVATIVE STARCH, AND 2,6-DIIZZBORNIL-4-METHYLPHENOL AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2619934C2 |
| HYDROPHILIC CONJUGATE OF HYDROXYETHYL STARCH AND 2,6-DIISOBORNYL-4-METHYLPHENOL | 2012 |
|
RU2497828C1 |
| NOVEL DERIVATIVES OF 2,6-DI-ISOBORNYL PHENOL AND METHOD OF OBTAINING THEREOF | 2012 |
|
RU2516699C2 |
| 2,6-DIISOBORNYLPHENOLS | 2011 |
|
RU2502719C2 |
